# Haploidentical Transplantation With Pre-Transplant Immunosuppressive Therapy for Patients With Sickle Cell Disease

> **NCT03279094** · PHASE1 · RECRUITING · sponsor: **City of Hope Medical Center** · enrollment: 11 (estimated)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **BIOLOGICAL:** Hematopoietic stem cell transplantation

## Key facts

- **NCT ID:** NCT03279094
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-02-02
- **Primary completion:** 2027-01-25
- **Final completion:** 2027-01-25
- **Target enrollment:** 11 (ESTIMATED)
- **Last updated:** 2026-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03279094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03279094, "Haploidentical Transplantation With Pre-Transplant Immunosuppressive Therapy for Patients With Sickle Cell Disease". Retrieved via AI Analytics 2026-07-21 from https://api.ai-analytics.org/clinical/NCT03279094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*